|
Market Cap (2-Jul) $77,044,616 (564th) |
Close (30-Jun) $0.180 |
Volume (30-Jun) 3,225,766 |
Shortsold (19-Jun) 12,988,365 (0.64%) (278th) |
|
52w High $0.073 |
52w Low $0.026 |
P/E - |
EPS -0.01 |
IPD released this announcement to the ASX on 19 October 2022, 16:11. The announcement is marked as price sensitive, and is 23 page(s) in length and 1.44MB in size.
You can view all announcements from IPD and see how they appear on a price chart on the announcements page.
At the date of this announcement, IPD was 0.193% short sold according to ASIC data. It was ranked the 420th most shorted stock on the ASX. It is now ranked as the 278th most shorted stock on the ASX with 0.641% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IPD | |
|---|---|
| Revised Security Trading Policy | 30 June 2023, 8:18 |
| ImpediMed Achieves Critical Mass in First Key Target State | 29 June 2023, 9:32 |
| ImpediMed Updates Board for Growth in Oncology | 28 June 2023, 8:22 |
| Appendix 4C & Quarterly Activities Report - Sep-22 Qtr | 19 October 2022, 16:11 |
| Quarterly Results and Investor Conference Call Notification | 13 October 2022, 11:11 |
| Clinical Update-NCCN Submissions, HSFA Posters, Lymphoedema | 12 October 2022, 13:06 |
| Notification of cessation of securities - IPD | 7 October 2022, 17:20 |
You must be logged in to post a reply.
ImpediMed 